<p>Groups of mice were immunized twice with 10mer selectant VLPs or wild-type MS2 VLPs. Serum was taken two-weeks following the boost. (A) Vaccine-elicited peptide titers were assessed by ELISA using recombinant PP7 bacteriophage VLPs displaying the NWDPTQFPGK peptide (in a surface-exposed AB loop similar to that of MS2) as the target antigen. (B) Antibody responses against native AMA1. In 3/10 vaccinated mice we observed low-titer cross-reactivity; these are referred to as “responders”. The remaining mice were characterized as “non-responders”. Mean OD<sub>405</sub> values are shown for each group. Error bars represent standard error of the mean, SEM.</p
<p>ELISA plates were coated with 2 μg/ml VLPs, gp120 Env, or Pr55 Gag. IgG1 quantitative ELISA of po...
<p>(A) C57Bl/6 mice were immunized <i>s.c.</i> on days 0 and 21 with 25 µg of MPLA and 1 µg of VMP00...
The titer of EV71 antibody in each of 5 groups of mice that received EV71 VLP (5μg), VLP (5μg) with ...
<p>Groups of mice were immunized with VLPs displaying the listed peptide sequences. Each group consi...
<p>(A) Anti-peptide responses in responder mice are enhanced by boosting with 25μg recombinant rAMA1...
<p><b>A</b>. Three groups of 16 BALB/c mice were immunized twice intraperitonealy with 10 µg of VLP-...
<p>Shown is the reactivity of sera from mice immunized with mixed L2 PP7 VLPs to L2 peptides. Mice w...
<p>Each group consisted of four female BALB/c mice immunized three times, two weeks apart via intram...
<p>(A) Groups of Balb/c mice were immunized twice intramuscularly at two-weeks interval with 5 µg ea...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Groups of three PvETRAMP11.2 (Black bar) and PvEXP1 (White bar) mice were immunized with the resp...
<p>BALB/c mice (n = 23 per group) were immunized twice by i.p. injection of 10 µg of VLP-1123, VLP-1...
<p>(A) Mice were immunized three times with DNA encoding different MPER display mutants and boosted ...
<p>Blood samples were collected through the retro-orbital plexus on day 7 after the last booster inj...
<p>Groups of five mice were injected i.p. at weeks 0, 2 and 5, with alum-absorbed antigens: EV71-VLP...
<p>ELISA plates were coated with 2 μg/ml VLPs, gp120 Env, or Pr55 Gag. IgG1 quantitative ELISA of po...
<p>(A) C57Bl/6 mice were immunized <i>s.c.</i> on days 0 and 21 with 25 µg of MPLA and 1 µg of VMP00...
The titer of EV71 antibody in each of 5 groups of mice that received EV71 VLP (5μg), VLP (5μg) with ...
<p>Groups of mice were immunized with VLPs displaying the listed peptide sequences. Each group consi...
<p>(A) Anti-peptide responses in responder mice are enhanced by boosting with 25μg recombinant rAMA1...
<p><b>A</b>. Three groups of 16 BALB/c mice were immunized twice intraperitonealy with 10 µg of VLP-...
<p>Shown is the reactivity of sera from mice immunized with mixed L2 PP7 VLPs to L2 peptides. Mice w...
<p>Each group consisted of four female BALB/c mice immunized three times, two weeks apart via intram...
<p>(A) Groups of Balb/c mice were immunized twice intramuscularly at two-weeks interval with 5 µg ea...
<p>(A) Regimen of prime and boost vaccination was followed by viral challenge. IM0, IM1, and IM2 rep...
<p>Groups of three PvETRAMP11.2 (Black bar) and PvEXP1 (White bar) mice were immunized with the resp...
<p>BALB/c mice (n = 23 per group) were immunized twice by i.p. injection of 10 µg of VLP-1123, VLP-1...
<p>(A) Mice were immunized three times with DNA encoding different MPER display mutants and boosted ...
<p>Blood samples were collected through the retro-orbital plexus on day 7 after the last booster inj...
<p>Groups of five mice were injected i.p. at weeks 0, 2 and 5, with alum-absorbed antigens: EV71-VLP...
<p>ELISA plates were coated with 2 μg/ml VLPs, gp120 Env, or Pr55 Gag. IgG1 quantitative ELISA of po...
<p>(A) C57Bl/6 mice were immunized <i>s.c.</i> on days 0 and 21 with 25 µg of MPLA and 1 µg of VMP00...
The titer of EV71 antibody in each of 5 groups of mice that received EV71 VLP (5μg), VLP (5μg) with ...